Navigation Links
Genes affect weight loss drug effectiveness
Date:9/30/2008

What:

A study conducted by researchers at Mayo Clinic shows that obese patients with specific genetic makeup had enhanced response to the weight loss drug sibutramine, while others who lack these genetic factors lost little or no weight.

The findings are published in the October issue of Gastroenterology (www.gastrojournal.org).

In this randomized, double-blind, placebo-controlled study, Mayo researchers measured the impact of two different dosage levels of sibutramine (10 or 15 mg daily) combined with behavioral therapy for 12 weeks in 181 overweight or obese participants. Participants received structured behavioral therapy for weight management at four, eight and 12 weeks.

As has been previously shown in trials with this approved medication, patients who received sibutramine and behavioral therapy lost significantly more weight than those who received placebo and the same behavioral therapy. Researchers also confirmed that weight loss at four weeks was a significant predictor of weight at 12 weeks, even after adjusting for baseline weight, gender, BMI and treatment.

Researchers explored the influence on weight and body composition of specific genetic markers indicative of variation in the function of two hormones/transmitters and an intracellular protein that mediates the function of those hormones. Patients with a certain pattern of variations of the genes lost an average of 10-12 pounds over the 12-week study, and those with unfavorable variations did worse.

Who:

Dr. Michael Camilleri, a Mayo Clinic gastroenterologist and the lead author of the study, is available for interviews. Please call Amy Tieder, Mayo Clinic Public Affairs, 507-284-5005, to make arrangements.

For audio and video:

Please also see Mayo Clinic news blog (http://newsblog.mayoclinic.org/2008/09/17/genes-weight-loss-drug-effectiveness/), password, e546f1 for audio and web video from Dr. Camilleri.


'/>"/>
Contact: Amy Tieder
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
3. New Database to Help Speed Search for Bipolar Disorder Genes
4. Is Perfect Pitch All in the Genes?
5. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
6. Genes Boost Risk for Rheumatoid Arthritis, Lupus
7. The genes involved in rheumatoid arthritis identified
8. If you think cancer genes are simple, you dont know JAK
9. Test for lung cancer looks for discomforting quiet among protective genes
10. Hushed Genes Might Mean Higher Lung Cancer Risk
11. EURYI project to understand how the brain wires during embryogenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... 2017 , ... "At your fingertips" electronic access to patient ... Delaware Health Information Network (DHIN) have partnered to improve connectivity of this data ... exchange, DHIN stores and shares real-time health data for more than 2 million ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, ... in the industry, according to the recent NEJM Catalyst Insights Report on the ... the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is a ... Davidson, NC. Dr. Brian Seese leads the practice as a skilled and highly credentialed ... roof. Smiles by Seese serves patients of all ages with excellence in general, restorative, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network ... prescribing of controlled and non-controlled substances plus the ability to manage orders on ... United States now accept electronic prescriptions, according to the Office of the National ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 2017 Provides understanding and access to ... into by the worlds leading healthcare companies. ... Description The Global Renal Failure Partnering Terms and ... to partnering deals and agreements entered into by ... Trends in partnering deals - Top deals ...
(Date:2/20/2017)... 20, 2017 The report analyzes the worldwide markets for Drug-Eluting ... the US, Canada , Japan ... Latin America , and Rest of World. ... ... provided for the period 2015 through 2022. Also, a six-year historic ...
(Date:2/20/2017)... Feb. 20, 2017 This report analyzes the worldwide ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , and Rest ... http://www.reportlinker.com/p04707131-summary/view-report.html Annual estimates and forecasts are provided ... analysis is provided for these markets. Market data and analytics ...
Breaking Medicine Technology: